BCK Capital Management’s Verona Pharma VRNA Stock Holding History

BCK Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,816	Closed	-$941K	–	53
2025 Q3	$941K	Buy	+8,816	New	+$921K	1%	41

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BCK Capital Management's VRNA Position: Q4 2025 in Review

BCK Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 8,816 shares — an estimated $941K sold.

BCK Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $941K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

BCK Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
BCK Capital Management sold 8,816 Verona Pharma shares in Q4 2025, an estimated $941K.
BCK Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
BCK Capital Management's Verona Pharma position peaked at $941K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on BCK Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.